IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q1 2015 Holdings

Filed 2015-05-05 | 17 holdings | $168.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Universal American Corp.COM98885E103$56.5K3,511,45633.5%
Orexigen Therapeutics, Inc.COM686164104$32.9K4,200,04719.5%
Epizyme, Inc.(EPZMEUR)COM29428V104$14.2K754,8068.4%
Auspex Pharmaceuticals, Inc.COM05211J102$7.5K75,0004.5%
Regulus Therapeutics Inc.COM75915K101$7.3K429,7234.3%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$6.6K210,0673.9%
Nexvet Biopharma public limited companyORD SHSG6503X109$5.7K708,3323.4%
Juno Therapeutics Inc.COM48205A109$5.6K91,5753.3%
Quotient LimitedSHSG73268107$5.6K326,5093.3%
Scynexis, Inc.COM811292101$5.5K662,9453.3%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$4.7K447,8782.8%
Alder Biopharmaceuticals Inc.COM14339105$4.5K157,1312.7%
Agile Therapeutics, Inc.(AGRXUSD)COM00847L100$4.3K459,2662.5%
T2 Biosystems, Inc.COM89853L104$3.6K233,0192.1%
Sangamo BioSciences, Inc.(SGMO)COM800677106$2.6K165,0001.5%
Ignyta, Inc.COM451731103$1.8K185,2201.1%